Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment

Acta Psychiatrica Scandinavica

Volumn 82, Issue 2, 1990, Pages 169-173

  Ferrarese, C ^a,b   Appollonio, I ^a,b   Frigo, M ^a,b   Perego, M ^a,b   Piolti, R ^a,b   Trabucchi, M ^b   Frattola, L ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

anxiety disorder; diazepam; lymphocyte; peripheral benzodiazepine receptor

Indexed keywords

BENZODIAZEPINE RECEPTOR; DIAZEPAM;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; DRUG THERAPY; FEMALE; HUMAN; LYMPHOCYTE; MALE; PSYCHOLOGICAL ASPECT; RECEPTOR DENSITY;

ANXIETY DISORDERS; DIAZEPAM; DOWN-REGULATION; HUMAN; LONG-TERM CARE; LYMPHOCYTES; NEUROPSYCHOLOGICAL TESTS; PERSONALITY TESTS; RECEPTORS, GABA-A;

EID: 0025113134     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1990.tb01376.x     Document Type: Article

References (40)

1. Behaviorally conditioned immunosuppression
2. Depressed lymphocyte function after bereavement
3. Impaired lymphocyte function in depressive illness
4. Lymphocyte function in major depressive disorder
5. Neuropeptides: conductors of the immune orchestra
6. Neuropeptides are shared components of nervous and immune system
7. Modulation of lymphocyte function by sensory neuropeptides
8. Beta adrenergic receptors and cyclic AMP levels in intact human lymphocytes: effects of age and gender
9. Binding of 3H‐spiperone to human lymphocytes: a biological marker in schizophrenia
10. Cholinergic muscarinic binding by human lymphocytes: changes with aging, antagonist treatment, and senile dementia of the Alzheimer type
11. Characterization of a peripheral‐type benzodiazepine binding site on human circulating lymphocytes
12. Characterization of peripheral benzodiazepine receptors in human blood mononuclear cells
13. Views of practicing psychiatrists on the treatment of anxiety and somatoform disorders
14. Current status of benzodiazepinesPart I
15. Current status of benzodiazepines. Part II
16. Molecular mechanisms mediating the action of diazepam on GABA receptors
17. High affinity renal 3H‐flunitrazepam binding: characterization, localization and alteration in hypertension
18. Benzodiazepines that bind at peripheral sites inhibit cell proliferation
19. The effects of central peripheral and mixed‐type benzodiazepine receptor ligands on the proliferation of mouse spleen lymphocytes
20. Benzodiazepine receptor‐mediated chemotaxis of human monocytes
21. Identification of des‐(Gly‐Ile)‐endozepine as an effector of corticotropin dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor
22. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis
23. Inescapable shock reduces 3H‐Ro 5‐4864 binding to “peripheral‐type” benzodiazepine receptors in the rat
24. “Peripheral” benzodiazepine binding sites in the Maudsley reactive rat: selective decrease confined to peripheral tissues
25. Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients
26. The assessment of anxiety states by rating
27. Organic anxiety syndrome
28. Hyperthyroidism and the organic anxiety syndrome
29. Anxiety or caffeinism: a diagnostic dilemma
30. The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans
31. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam
32. A rating scale for depression
33. Rapid preparation for lymphocytes for tissue typing
34. Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO 5‐4864, in a conflict situation in the rat
35. Endogenous inhibitors of 4′‐3H‐chlordiazepam (RO 5‐4864) binding to “peripheral” sites for benzodiazepines
36. Inhibitors of peripheral type benzodiazepine receptors present in human urine and plasma ultrafiltrates
37. A benzodiazepine receptor‐mediated model of anxiety. Studies in nonhuman primates and clinical implications
38. Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on BDZ receptors